Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
ZNF644	84146	broad.mit.edu	37	1	91404393	91404393	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr1:91404393C>T	ENST00000370440.1	-	3	2735	c.2518G>A	c.(2518-2520)Gtt>Att	p.V840I	ZNF644_ENST00000361321.5_Intron|ZNF644_ENST00000337393.5_Missense_Mutation_p.V840I|ZNF644_ENST00000347275.5_Intron|ZNF644_ENST00000467231.1_Intron			Q9H582	ZN644_HUMAN	zinc finger protein 644	840		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding		NA	breast(4)|endometrium(2)|large_intestine(10)|lung(21)|ovary(2)|skin(5)|upper_aerodigestive_tract(1)|urinary_tract(2)	47		all_lung(203;0.00206)|Lung NSC(277;0.0519)|Lung SC(238;0.101)		all cancers(265;0.00102)|Epithelial(280;0.00766)|KIRC - Kidney renal clear cell carcinoma(1967;0.147)|OV - Ovarian serous cystadenocarcinoma(397;0.173)		TTTTGCAAAACGACAACAGTC	0.363	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						69	72	71	NA		NA	NA	1		NA											NA				91404393		2203	4297	6500	SO:0001583	missense			ENSG00000122482	HGNC:29222	NM_032186	Approved	uc001dnw.3	NA	A2RU71|Q2TAM0|Q5TCC0|Q6BEP7|Q6P446|Q6PI06|Q7LG67|Q9ULJ9	ENST00000370440.1	37	CCDS731.1	.	.	.	.	.	.	.	.	.	.	C	14.95	2.688640	0.48097	.	.	ENSG00000122482	ENST00000370440;ENST00000337393;ENST00000536941	T;T	0.53640	0.61;0.61	5.7	5.7	0.88788	.	0.236438	0.34932	N	0.003574	T	0.20941	0.0504	L	0.32530	0.975	0.34770	D	0.733633	P	0.43938	0.822	B	0.30716	0.119	T	0.12708	-1.0537	10	0.37606	T	0.19	-12.4562	16.8263	0.85933	0.0:0.8718:0.1282:0.0	.	840	Q9H582	ZN644_HUMAN	I	840;840;412	ENSP00000359469:V840I;ENSP00000337008:V840I	ENSP00000337008:V840I	V	-	1	0	ZNF644	91176981	1.000000	0.71417	1.000000	0.80357	0.987000	0.75469	3.784000	0.55416	2.692000	0.91855	0.591000	0.81541	GTT	ZNF644-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000027846.2	248.494613	KEEP		-	252.179349	0.368852	90	154	---	---	---	---	1	0.9685067	5	7	1	185	93	155	1	185	2	0	0	0	0	0	0	93	155	1	185	2	TP
SIPA1L2	57568	broad.mit.edu	37	1	232561420	232561420	+	Silent	SNP	G	G	A			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr1:232561420G>A	ENST00000366630.1	-	17	4903	c.4545C>T	c.(4543-4545)aaC>aaT	p.N1515N	SIPA1L2_ENST00000262861.4_Silent_p.N1515N|SIPA1L2_ENST00000308942.4_Silent_p.N589N			Q9P2F8	SI1L2_HUMAN	signal-induced proliferation-associated 1 like 2	1515		NA			regulation of small GTPase mediated signal transduction	intracellular	GTPase activator activity		NA	NS(1)|breast(5)|central_nervous_system(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(13)|lung(49)|ovary(2)|pancreas(1)|prostate(2)|skin(3)|upper_aerodigestive_tract(2)	103		all_cancers(173;0.00605)|Prostate(94;0.128)|all_epithelial(177;0.186)				ACAGAATGTCGTTGGGCAGGG	0.642	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	G		1,4403	2.1+/-5.4	0,1,2201	71	85	80	NA	4545	-0.6	1	1		80	0,8590		0,0,4295	no	coding-synonymous	SIPA1L2	NM_020808.3		0,1,6496	AA,AG,GG	NA	0.0,0.0227,0.0077		1515/1723	232561420	1,12993	2202	4295	6497	SO:0001819	synonymous_variant			ENSG00000116991	HGNC:23800	XM_045839	Approved	uc001hvg.3	NA	Q2TV88|Q5VXR7|Q5VXR8|Q641Q4|Q8NA38|Q96DZ3|Q9H9F6	ENST00000366630.1	37	CCDS41474.1																																																																																			SIPA1L2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000092318.1	48.867651	KEEP		-	51.158134	0.30303	20	46	---	---	---	---	1	0.8577982	2	8	1	53	23	51	1	53	2	0	0	0	0	0	0	23	51	1	53	2	TP
MYCN	4613	broad.mit.edu	37	2	16082359	16082359	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr2:16082359C>T	ENST00000281043.3	+	2	470	c.173C>T	c.(172-174)aCg>aTg	p.T58M	MYCNOS_ENST00000448719.1_RNA|MYCNOS_ENST00000420452.1_RNA|MYCNOS_ENST00000439180.1_RNA|MYCNOS_ENST00000453400.1_RNA|MYCNOS_ENST00000419083.1_RNA	NM_005378.4	NP_005369.2	P04198	MYCN_HUMAN	v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog	58		NA			regulation of transcription from RNA polymerase II promoter	chromatin|nucleus	DNA binding|protein binding|sequence-specific DNA binding transcription factor activity		NA	NS(2)|autonomic_ganglia(1)|breast(1)|central_nervous_system(4)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|prostate(1)|skin(2)|urinary_tract(1)	31	all_cancers(1;1.35e-08)|all_neural(1;2.92e-24)|Lung SC(1;3.26e-07)|Medulloblastoma(1;6.9e-06)|all_lung(1;1.26e-05)|Glioma(3;0.135)|Acute lymphoblastic leukemia(172;0.155)|all_epithelial(1;0.169)|all_hematologic(175;0.197)		GBM - Glioblastoma multiforme(3;0.000332)			CTGCTGCCCACGCCCCCGCTG	0.677	NA	NA	A		neuroblastoma		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		2	2p24.1	4613	"""v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)"""	NA	O	0							NA						17	20	19	NA		NA	NA	2		NA											NA				16082359		2200	4300	6500	SO:0001583	missense			ENSG00000134323	HGNC:7559	NM_005378	Approved	uc002rci.3	NA	Q6LDT9	ENST00000281043.3	37	CCDS1687.1	.	.	.	.	.	.	.	.	.	.	C	23.1	4.370939	0.82573	.	.	ENSG00000134323	ENST00000281043;ENST00000426211	T	0.30448	1.53	2.89	2.89	0.33648	Transcription regulator Myc, N-terminal (1);	0.369160	0.30036	N	0.010568	T	0.59376	0.2189	M	0.87269	2.87	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	T	0.69851	-0.5033	10	0.66056	D	0.02	-14.876	14.556	0.68101	0.0:1.0:0.0:0.0	.	58	P04198	MYCN_HUMAN	M	58	ENSP00000281043:T58M	ENSP00000281043:T58M	T	+	2	0	MYCN	15999810	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.495000	0.81514	1.567000	0.49668	0.561000	0.74099	ACG	MYCN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000095469.2	50.83081	KEEP		+	51.202018	0.404255	19	28	---	---	---	---	1	0.8240284	2	5	0	45	19	29	0	45	2	0	0	0	0	0	0	19	29	0	45	2	TP
SCN9A	6335	broad.mit.edu	37	2	167141183	167141183	+	Missense_Mutation	SNP	C	C	G			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr2:167141183C>G	ENST00000303354.6	-	12	2097	c.1757G>C	c.(1756-1758)aGg>aCg	p.R586T	SCN9A_ENST00000409672.1_Missense_Mutation_p.R585T|AC010127.3_ENST00000447809.2_RNA|SCN9A_ENST00000409435.1_Missense_Mutation_p.R585T|SCN9A_ENST00000375387.4_Missense_Mutation_p.R586T			Q15858	SCN9A_HUMAN	sodium channel, voltage-gated, type IX, alpha subunit	585		NA				voltage-gated sodium channel complex	voltage-gated sodium channel activity		NA	NS(1)|breast(5)|central_nervous_system(6)|endometrium(6)|kidney(3)|large_intestine(27)|lung(38)|ovary(6)|prostate(8)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(2)	108					Lamotrigine(DB00555)|Lidocaine(DB00281)	CAGTGAGCCCCTTCTGCTCTC	0.502	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						108	113	111	NA		NA	NA	2		NA											NA				167141183		2108	4247	6355	SO:0001583	missense			ENSG00000169432	HGNC:10597	NM_002977	Approved	uc010fpl.3	NA	A1BUH5|Q6B4R9|Q6B4S0|Q6B4S1|Q70HX1|Q70HX2|Q8WTU1|Q8WWN4	ENST00000303354.6	37		.	.	.	.	.	.	.	.	.	.	C	23.8	4.462096	0.84425	.	.	ENSG00000169432	ENST00000409672;ENST00000375387;ENST00000303354;ENST00000409435;ENST00000454569;ENST00000452182	D;D;D;D;D;D	0.96554	-4.0;-4.02;-4.02;-4.02;-4.0;-4.05	5.64	5.64	0.86602	Domain of unknown function DUF3451 (1);	0.000000	0.64402	D	0.000001	D	0.98375	0.9460	M	0.91872	3.25	0.50039	D	0.999845	P;D;P	0.65815	0.781;0.995;0.578	P;D;B	0.76071	0.68;0.987;0.296	D	0.98855	1.0760	10	0.87932	D	0	.	14.2623	0.66092	0.0:0.9286:0.0:0.0714	.	585;585;586	E7EUN6;Q15858;E9PF08	.;SCN9A_HUMAN;.	T	585;586;586;585;450;450	ENSP00000386306:R585T;ENSP00000364536:R586T;ENSP00000304748:R586T;ENSP00000386330:R585T;ENSP00000413212:R450T;ENSP00000393141:R450T	ENSP00000304748:R586T	R	-	2	0	SCN9A	166849429	0.980000	0.34600	1.000000	0.80357	0.988000	0.76386	4.630000	0.61297	2.812000	0.96745	0.557000	0.71058	AGG	SCN9A-201	KNOWN	basic	protein_coding	NA	protein_coding		228.565048	KEEP		-	230.218602	0.39779	72	109	---	---	---	---	0	0	0	0	0	153	76	116	0	153	2	1	1	113	232	0	355	76	116	0	153	2	TP
OXSM	54995	broad.mit.edu	37	3	25832620	25832620	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr3:25832620A>G	ENST00000280701.3	+	2	208	c.109A>G	c.(109-111)Ata>Gta	p.I37V	OXSM_ENST00000449808.1_3'UTR|OXSM_ENST00000420173.2_Missense_Mutation_p.I37V|NGLY1_ENST00000417874.2_5'Flank	NM_017897.2	NP_060367.1	Q9NWU1	OXSM_HUMAN	3-oxoacyl-ACP synthase, mitochondrial	37		NA			acyl-CoA metabolic process|medium-chain fatty acid biosynthetic process|short-chain fatty acid biosynthetic process	mitochondrion	3-oxoacyl-[acyl-carrier-protein] synthase activity		NA	breast(1)|cervix(1)|endometrium(1)|kidney(3)|large_intestine(5)|lung(9)|ovary(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	25						AACTGTGCCAATATCCAGATT	0.428	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA	A	VAL/ILE,VAL/ILE	1,4405	2.1+/-5.4	0,1,2202	157	149	151	NA	109,109	-3.5	0	3		151	0,8600		0,0,4300	no	missense,missense	OXSM	NM_017897.2,NM_001145391.1	29,29	0,1,6502	GG,GA,AA	NA	0.0,0.0227,0.0077	benign,benign	37/460,37/377	25832620	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000151093	HGNC:26063	NM_017897	Approved	uc003cdn.3	NA		ENST00000280701.3	37	CCDS2643.1	.	.	.	.	.	.	.	.	.	.	A	0.004	-2.305625	0.00240	2.27E-4	0.0	ENSG00000151093	ENST00000452098;ENST00000280701;ENST00000420173;ENST00000428266	.	.	.	5.14	-3.49	0.04724	.	0.951080	0.08789	N	0.893524	T	0.12902	0.0313	N	0.08118	0	0.09310	N	1	B;B	0.06786	0.001;0.0	B;B	0.08055	0.003;0.0	T	0.29181	-1.0020	9	0.13108	T	0.6	-0.9961	2.4324	0.04475	0.3055:0.2118:0.3692:0.1135	.	37;37	Q9NWU1-2;Q9NWU1	.;OXSM_HUMAN	V	37	.	ENSP00000280701:I37V	I	+	1	0	OXSM	25807624	0.000000	0.05858	0.000000	0.03702	0.173000	0.22820	-0.000000	0.12993	-0.399000	0.07668	0.459000	0.35465	ATA	OXSM-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000252876.2	503.836959	KEEP		+	507.553265	0.391061	140	218	---	---	---	---	1	0.9987624	6	13	0	325	155	240	0	325	2	0	0	0	0	0	0	155	240	0	325	2	TP
TIGIT	201633	broad.mit.edu	37	3	114027084	114027084	+	3'UTR	SNP	A	A	G	rs72509136		GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr3:114027084A>G	ENST00000481065.1	+	0	3657				TIGIT_ENST00000383671.3_3'UTR|TIGIT_ENST00000486257.1_3'UTR			Q495A1	TIGIT_HUMAN	T cell immunoreceptor with Ig and ITIM domains	NA		NA			negative regulation of interleukin-12 production|negative regulation of T cell activation|positive regulation of interleukin-10 production	cell surface|integral to membrane|plasma membrane	protein binding		NA	breast(1)|central_nervous_system(1)|cervix(1)|endometrium(2)|large_intestine(4)|lung(7)|prostate(1)	17						gtgtgtgtgtatgtgtgtgtg	0.408	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000181847	HGNC:26838	NM_173799	Approved	uc003ebg.2	NA	Q495A3|Q5JPD8|Q6MZS2|Q8N877	ENST00000481065.1	37																																																																																				TIGIT-001	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000354689.1	-2.08061	KEEP		+	12.780802	0.065789	5	71	---	---	---	---	1	0.04077551	2	2	1	53	6	76	1	53	2	0	0	0	0	0	0	6	76	1	53	2	TP
PIK3CA	5290	broad.mit.edu	37	3	178916882	178916882	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr3:178916882G>A	ENST00000263967.3	+	2	426	c.269G>A	c.(268-270)tGt>tAt	p.C90Y		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	90	PI3K-ABD.	NA			epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity		NA	NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			AGACGACTTTGTGACCTTCGG	0.368	NA	57	Mis		"""colorectal, gastric, gliobastoma, breast"""		NA			HNSCC(19;0.045)|TSP Lung(28;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""	NA	"""E, O"""	0							NA						106	101	103	NA		NA	NA	3		NA											NA				178916882		1820	4077	5897	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	G	21.5	4.163066	0.78226	.	.	ENSG00000121879	ENST00000263967;ENST00000468036	T;T	0.75367	-0.93;-0.93	5.44	5.44	0.79542	Phosphatidylinositol 3-kinase, p85-binding (2);	0.000000	0.85682	D	0.000000	D	0.87176	0.6112	M	0.80422	2.495	0.80722	D	1	D	0.89917	1.0	D	0.81914	0.995	D	0.87276	0.2289	9	.	.	.	-21.1026	19.2635	0.93977	0.0:0.0:1.0:0.0	.	90	P42336	PK3CA_HUMAN	Y	90	ENSP00000263967:C90Y;ENSP00000417479:C90Y	.	C	+	2	0	PIK3CA	180399576	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	9.409000	0.97331	2.547000	0.85894	0.555000	0.69702	TGT	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	-5.506612	KEEP		+	32.364164	0.080569	17	194	---	---	---	---	0	0.006012447	0	2	0	205	17	218	0	205	2	1	1	28	483	0	491	17	218	0	205	2	TP
HSP90AB1	3326	broad.mit.edu	37	6	44217321	44217321	+	Splice_Site	SNP	G	G	T			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr6:44217321G>T	ENST00000371554.1	+	3	568		c.e3+1		HSP90AB1_ENST00000371646.5_Splice_Site|HSP90AB1_ENST00000353801.3_Splice_Site			P08238	HS90B_HUMAN	heat shock protein 90kDa alpha (cytosolic), class B member 1	NA		NA			axon guidance|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of nitric oxide biosynthetic process|protein folding|regulation of interferon-gamma-mediated signaling pathway|regulation of type I interferon-mediated signaling pathway|response to unfolded protein	cytosol|melanosome	ATP binding|nitric-oxide synthase regulator activity|TPR domain binding|unfolded protein binding		NA	NS(1)|breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(12)|prostate(2)|skin(2)|urinary_tract(2)	33	all_cancers(18;1.7e-05)|all_lung(25;0.00747)|Hepatocellular(11;0.00908)|Ovarian(13;0.0273)		Colorectal(64;0.00337)|COAD - Colon adenocarcinoma(64;0.00536)			GGCTCTTCAGGTATTGCAGTT	0.403	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						82	82	82	NA		NA	NA	6		NA											NA				44217321		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000096384	HGNC:5258	NM_007355	Approved	uc031sor.1	NA	B2R5P0|Q5T9W7|Q9NQW0|Q9NTK6	ENST00000371554.1	37	CCDS4909.1	.	.	.	.	.	.	.	.	.	.	G	19.00	3.742751	0.69418	.	.	ENSG00000096384	ENST00000371646;ENST00000353801;ENST00000371554	.	.	.	4.21	4.21	0.49690	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	17.4677	0.87638	0.0:0.0:1.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	HSP90AB1	44325299	.	.	1.000000	0.80357	0.874000	0.50279	.	.	2.289000	0.77006	0.561000	0.74099	.	HSP90AB1-005	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040730.1	247.047911	KEEP	Intron	+	249.444197	0.385714	81	129	---	---	---	---	1	1	10	149	0	180	86	141	0	180	2	0	0	0	0	0	0	86	141	0	180	2	TP
AVL9	23080	broad.mit.edu	37	7	32956992	32956992	+	Intron	SNP	T	T	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr7:32956992T>C	ENST00000404479.1	+	11	1215				RP9P_ENST00000381639.3_RNA			Q8NBF6	AVL9_HUMAN	AVL9 homolog (S. cerevisiase)	NA		NA				integral to membrane			NA	endometrium(3)|kidney(1)|large_intestine(3)|lung(7)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	18						ACTTGGAAGATTTGTGCTTCC	0.378	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000105778	HGNC:28994	NM_015060	Approved	uc003tcv.1	NA	Q92573	ENST00000404479.1	37																																																																																				AVL9-201	KNOWN	basic	protein_coding	NA	protein_coding		301.728346	KEEP		+	314.24122	0.288462	90	222	---	---	---	---	1	1	19	50	0	162	90	223	0	162	2	0	0	0	0	0	0	90	223	0	162	2	TP
KCTD7	154881	broad.mit.edu	37	7	66262470	66262470	+	Silent	SNP	T	T	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr7:66262470T>C	ENST00000380828.2	+	8	979	c.825T>C	c.(823-825)gaT>gaC	p.D275D	KCTD7_ENST00000451741.2_Silent_p.D235D|RABGEF1_ENST00000450873.2_Silent_p.D235D|RABGEF1_ENST00000284957.5_Silent_p.D235D|RABGEF1_ENST00000439720.2_Silent_p.D248D|RABGEF1_ENST00000437078.2_Silent_p.D249D|KCTD7_ENST00000510829.2_Silent_p.D235D|RABGEF1_ENST00000484547.2_3'UTR			Q96MP8	KCTD7_HUMAN	potassium channel tetramerization domain containing 7	0		NA				voltage-gated potassium channel complex	voltage-gated potassium channel activity		NA	central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(5)|ovary(2)|urinary_tract(1)	16						AGAAGAAAGATCTTGCCATTC	0.358	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						68	65	66	NA		NA	NA	7		NA											NA				66262470		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000243335	HGNC:21957	NM_153033	Approved	uc003tve.3	NA	A4D2M4|Q8IVR0	ENST00000380828.2	37																																																																																				KCTD7-201	KNOWN	basic	protein_coding	NA	protein_coding		180.12575	KEEP		+	190.893233	0.265116	57	158	---	---	---	---	1	0.9975878	8	20	0	143	66	179	0	143	2	0	0	0	0	0	0	66	179	0	143	2	TP
PARP12	64761	broad.mit.edu	37	7	139724367	139724367	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr7:139724367C>T	ENST00000263549.3	-	12	2972	c.2099G>A	c.(2098-2100)cGa>cAa	p.R700Q		NM_022750.2	NP_073587.1	Q9H0J9	PAR12_HUMAN	poly (ADP-ribose) polymerase family, member 12	700		NA				nucleus	NAD+ ADP-ribosyltransferase activity|nucleic acid binding|zinc ion binding		NA	endometrium(3)|kidney(2)|large_intestine(4)|lung(5)|ovary(3)|prostate(1)|skin(1)	19	Melanoma(164;0.0142)					CGCTCACTGTCGGCTGCTGAA	0.522	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						77	66	70	NA		NA	NA	7		NA											NA				139724367		2203	4300	6503	SO:0001583	missense			ENSG00000059378	HGNC:21919	NM_022750	Approved	uc003vvl.1	NA	Q9H610|Q9NP36|Q9NTI3	ENST00000263549.3	37	CCDS5857.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	18.93|18.93	3.727720|3.727720	0.69074|0.69074	.|.	.|.	ENSG00000059378|ENSG00000059378	ENST00000541746|ENST00000263549	.|T	.|0.08008	.|3.14	4.67|4.67	3.78|3.78	0.43462|0.43462	.|.	.|0.147317	.|0.29737	.|N	.|0.011330	T|T	0.09247|0.09247	0.0228|0.0228	L|L	0.51422|0.51422	1.61|1.61	0.09310|0.09310	N|N	1|1	.|B	.|0.26081	.|0.141	.|B	.|0.17098	.|0.017	T|T	0.17623|0.17623	-1.0363|-1.0363	6|10	0.62326|0.72032	D|D	0.03|0.01	.|.	11.0652|11.0652	0.47972|0.47972	0.0:0.8119:0.1881:0.0|0.0:0.8119:0.1881:0.0	.|.	.|700	.|Q9H0J9	.|PAR12_HUMAN	N|Q	84|700	.|ENSP00000263549:R700Q	ENSP00000445106:D84N|ENSP00000263549:R700Q	D|R	-|-	1|2	0|0	PARP12|PARP12	139370836|139370836	0.001000|0.001000	0.12720|0.12720	0.004000|0.004000	0.12327|0.12327	0.091000|0.091000	0.18340|0.18340	0.499000|0.499000	0.22546|0.22546	1.066000|1.066000	0.40716|0.40716	0.655000|0.655000	0.94253|0.94253	GAC|CGA	PARP12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348413.1	92.280829	KEEP		-	92.981365	0.4	32	48	---	---	---	---	1	1	19	77	0	63	38	65	0	63	2	0	0	0	0	0	0	38	65	0	63	2	TP
SLC4A2	6522	broad.mit.edu	37	7	150759094	150759094	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr7:150759094G>A	ENST00000485713.1	+	2	1060	c.20G>A	c.(19-21)cGc>cAc	p.R7H	SLC4A2_ENST00000413384.2_Missense_Mutation_p.R7H|SLC4A2_ENST00000392826.2_5'Flank|SLC4A2_ENST00000310317.5_Missense_Mutation_p.R7H|SLC4A2_ENST00000461735.1_5'Flank	NM_001199692.1	NP_001186621.1	P04920	B3A2_HUMAN	solute carrier family 4 (anion exchanger), member 2	7	Pro-rich.	NA		R -> L (in Ref. 1; CAA44067).	bicarbonate transport	integral to membrane|membrane fraction	inorganic anion exchanger activity	p.R7L(1)	NA	NS(1)|central_nervous_system(2)|endometrium(3)|kidney(1)|large_intestine(2)|liver(2)|lung(14)|prostate(3)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(1)	33			OV - Ovarian serous cystadenocarcinoma(82;0.0121)	UCEC - Uterine corpus endometrioid carcinoma (81;0.168)		GCCCCTCGGCGCCCCGCCAAG	0.667	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		1	Substitution - Missense(1)	prostate(1)					NA						25	27	26	NA		NA	NA	7		NA											NA				150759094		2203	4298	6501	SO:0001583	missense			ENSG00000164889	HGNC:11028	NM_003040	Approved	uc003wit.4	NA	B2R6T0|D3DX05|Q45EY5|Q969L3	ENST00000485713.1	37	CCDS5917.1	.	.	.	.	.	.	.	.	.	.	G	16.40	3.112432	0.56398	.	.	ENSG00000164889	ENST00000483786;ENST00000485713;ENST00000413384;ENST00000490898;ENST00000482950;ENST00000463414;ENST00000310317;ENST00000488420	T;T;T;T;T;T;T;T	0.80033	0.52;-1.13;-1.13;1.08;0.55;0.53;-1.33;-0.04	4.69	4.69	0.59074	.	2.103280	0.02303	N	0.071413	T	0.70500	0.3231	L	0.36672	1.1	0.22366	N	0.999168	P	0.48640	0.913	B	0.31337	0.128	T	0.60611	-0.7229	10	0.13108	T	0.6	.	13.0013	0.58676	0.0:0.0:1.0:0.0	.	7	P04920	B3A2_HUMAN	H	7	ENSP00000417808:R7H;ENSP00000419412:R7H;ENSP00000405600:R7H;ENSP00000418114:R7H;ENSP00000419379:R7H;ENSP00000418584:R7H;ENSP00000311402:R7H;ENSP00000417221:R7H	ENSP00000311402:R7H	R	+	2	0	SLC4A2	150390027	0.995000	0.38212	1.000000	0.80357	0.138000	0.21146	1.751000	0.38339	2.424000	0.82194	0.561000	0.74099	CGC	SLC4A2-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000351039.1	38.738749	KEEP		+	41.642323	0.276923	18	47	---	---	---	---	1	0.920027	3	12	0	32	21	60	0	32	2	0	0	0	0	0	0	21	60	0	32	2	TP
EPC1	80314	broad.mit.edu	37	10	32580102	32580102	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr10:32580102T>C	ENST00000319778.6	-	6	1266	c.964A>G	c.(964-966)Aaa>Gaa	p.K322E	EPC1_ENST00000263062.8_Missense_Mutation_p.K322E|EPC1_ENST00000375110.2_Missense_Mutation_p.K272E	NM_001272004.1|NM_001272019.1	NP_001258933.1|NP_001258948.1	Q9H2F5	EPC1_HUMAN	enhancer of polycomb homolog 1 (Drosophila)	322		NA			histone H2A acetylation|histone H4 acetylation|negative regulation of gene expression, epigenetic|negative regulation of transcription from RNA polymerase II promoter|positive regulation of transcription from RNA polymerase II promoter|regulation of growth|transcription, DNA-dependent	NuA4 histone acetyltransferase complex|nuclear membrane|Piccolo NuA4 histone acetyltransferase complex			NA	breast(2)|central_nervous_system(1)|cervix(1)|endometrium(1)|kidney(2)|large_intestine(3)|lung(8)|ovary(5)|urinary_tract(1)	24		Prostate(175;0.0199)				TTATTAACTTTGAACTCCTTC	0.333	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						133	121	125	NA		NA	NA	10		NA											NA				32580102		2203	4300	6503	SO:0001583	missense			ENSG00000120616	HGNC:19876		Approved	uc001iwg.2	NA	B4DSC3|D3DRX7|Q5VW54|Q5VW56|Q5VW58|Q8NAQ4|Q8NE21|Q96LF4|Q96RR6|Q9H7T7	ENST00000319778.6	37		.	.	.	.	.	.	.	.	.	.	T	14.64	2.597092	0.46318	.	.	ENSG00000120616	ENST00000375110;ENST00000319778;ENST00000263062	T;T;T	0.68025	-0.3;-0.3;-0.3	5.62	5.62	0.85841	.	0.000000	0.85682	D	0.000000	T	0.65831	0.2729	M	0.65975	2.015	0.58432	D	0.999995	B;B;B;B	0.30686	0.264;0.29;0.127;0.001	B;B;B;B	0.34590	0.186;0.12;0.087;0.011	T	0.62172	-0.6910	10	0.12103	T	0.63	-17.1925	16.1135	0.81278	0.0:0.0:0.0:1.0	.	322;272;322;322	B8XCX7;Q9H2F5-3;Q9H2F5-2;Q9H2F5	.;.;.;EPC1_HUMAN	E	272;322;322	ENSP00000364251:K272E;ENSP00000318559:K322E;ENSP00000263062:K322E	ENSP00000263062:K322E	K	-	1	0	EPC1	32620108	1.000000	0.71417	0.996000	0.52242	0.989000	0.77384	7.175000	0.77632	2.267000	0.75376	0.383000	0.25322	AAA	EPC1-002	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000047482.1	180.1275	KEEP		-	182.276676	0.685714	48	22	---	---	---	---	1	0.9782645	5	1	0	114	49	24	0	114	2	0	0	0	0	0	0	49	24	0	114	2	TP
PEX11A	8800	broad.mit.edu	37	15	90226620	90226620	+	Silent	SNP	C	C	T			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr15:90226620C>T	ENST00000300056.3	-	3	881	c.732G>A	c.(730-732)ctG>ctA	p.L244L	PEX11A_ENST00000557982.1_Intron|PEX11A_ENST00000561257.1_Silent_p.L213L|PEX11A_ENST00000559170.1_3'UTR|PEX11A_ENST00000561224.1_Intron	NM_001271573.1	NP_001258502.1	O75192	PX11A_HUMAN	peroxisomal biogenesis factor 11 alpha	244		NA			cellular lipid metabolic process|peroxisome fission|signal transduction	integral to peroxisomal membrane			NA	endometrium(2)|large_intestine(2)|lung(3)	7	Lung NSC(78;0.0237)|all_lung(78;0.0478)		KIRC - Kidney renal clear cell carcinoma(17;0.0286)|Kidney(142;0.0514)|BRCA - Breast invasive adenocarcinoma(143;0.128)			AACGGGTCTTCAGCTTCATCT	0.453	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						203	209	207	NA		NA	NA	15		NA											NA				90226620		2200	4299	6499	SO:0001819	synonymous_variant			ENSG00000166821	HGNC:8852	NM_003847	Approved	uc002boi.4	NA		ENST00000300056.3	37	CCDS10354.1																																																																																			PEX11A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000313420.1	642.754296	KEEP		-	649.076	0.388215	224	353	---	---	---	---	1	0.9961394	11	6	0	523	244	402	0	523	2	0	0	0	0	0	0	244	402	0	523	2	TP
ZNF23	7571	broad.mit.edu	37	16	71488085	71488085	+	5'UTR	SNP	T	T	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr16:71488085T>C	ENST00000393539.2	-	0	707				ZNF23_ENST00000539742.1_Intron|ZNF23_ENST00000497160.1_Intron|ZNF23_ENST00000358700.2_Intron|ZNF23_ENST00000564528.1_5'Flank|ZNF23_ENST00000417828.1_5'UTR|RP11-510M2.10_ENST00000576258.1_RNA|AC010547.9_ENST00000561908.1_Intron|ZNF23_ENST00000357254.4_5'UTR|ZNF23_ENST00000428724.2_Intron	NM_145911.1	NP_666016.1	P17027	ZNF23_HUMAN	zinc finger protein 23	NA		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding		NA	NS(1)|central_nervous_system(2)|endometrium(2)|kidney(1)|large_intestine(7)|lung(14)|stomach(1)|urinary_tract(1)	29		Ovarian(137;0.00768)		BRCA - Breast invasive adenocarcinoma(221;0.0686)		AAACAATAGGTTCCTGCTGCC	0.562	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001623	5_prime_UTR_variant			ENSG00000167377	HGNC:13023	NM_145911	Approved	uc002faf.3	NA	Q96IT3|Q9UG42	ENST00000393539.2	37	CCDS10900.1																																																																																			ZNF23-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000268985.20	77.262498	KEEP		-	78.129107	0.368421	21	36	---	---	---	---	1	0.316353	2	1	0	60	24	41	0	60	2	0	0	0	0	0	0	24	41	0	60	2	TP
TP53	7157	broad.mit.edu	37	17	7578534	7578534	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr17:7578534C>A	ENST00000420246.2	-	5	528	c.396G>T	c.(394-396)aaG>aaT	p.K132N	TP53_ENST00000413465.2_Missense_Mutation_p.K132N|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000359597.4_Missense_Mutation_p.K132N|TP53_ENST00000269305.4_Missense_Mutation_p.K132N|TP53_ENST00000445888.2_Missense_Mutation_p.K132N|TP53_ENST00000455263.2_Missense_Mutation_p.K132N	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	132	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	K -> E (in LFS; germline mutation and in sporadic cancers; somatic mutation).|K -> L (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|K -> M (in sporadic cancers; somatic mutation).|K -> N (in sporadic cancers; somatic mutation).|K -> Q (in sporadic cancers; somatic mutation).|K -> R (in sporadic cancers; somatic mutation).|K -> T (in sporadic cancers; somatic mutation).|K -> W (in a sporadic cancer; somatic mutation; requires 2 nucleotide substitutions).|KM -> NL (in a sporadic cancer; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.K132N(49)|p.0?(8)|p.Y126_K132delYSPALNK(6)|p.K39N(2)|p.N131fs*27(2)|p.V73fs*9(1)|p.S127fs*36(1)|p.A129_K132delALNK(1)|p.Y126fs*11(1)|p.K132K(1)|p.K132_A138delKMFCQLA(1)|p.S127_Q136del10(1)|p.L130_M133delLNKM(1)|p.M133fs*37(1)|p.M133fs*16(1)	NA	NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GGCAAAACATCTTGTTGAGGG	0.562	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	77	Substitution - Missense(51)|Deletion - In frame(10)|Whole gene deletion(8)|Deletion - Frameshift(6)|Insertion - Frameshift(1)|Substitution - coding silent(1)	urinary_tract(13)|breast(10)|ovary(10)|lung(9)|large_intestine(8)|haematopoietic_and_lymphoid_tissue(6)|central_nervous_system(4)|bone(4)|adrenal_gland(3)|upper_aerodigestive_tract(2)|skin(2)|liver(2)|stomach(1)|penis(1)|oesophagus(1)|pancreas(1)					NA						47	48	48	NA		NA	NA	17		NA											NA				7578534		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	21.7	4.186174	0.78789	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000514944;ENST00000508793	D;D;D;D;D;D;D;D	0.99859	-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23;-7.23	5.48	3.5	0.40072	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99857	0.9933	M	0.91768	3.24	0.58432	D	0.999999	D;D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	0.998;0.998;0.993;0.996;0.999;0.998;1.0	D	0.97328	0.9948	10	0.87932	D	0	-14.0777	10.5581	0.45129	0.0:0.841:0.0:0.159	.	93;132;132;39;132;132;132	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	N	132;132;132;132;132;132;121;39;39;132	ENSP00000410739:K132N;ENSP00000352610:K132N;ENSP00000269305:K132N;ENSP00000398846:K132N;ENSP00000391127:K132N;ENSP00000391478:K132N;ENSP00000423862:K39N;ENSP00000424104:K132N	ENSP00000269305:K132N	K	-	3	2	TP53	7519259	1.000000	0.71417	0.994000	0.49952	0.784000	0.44337	1.646000	0.37249	0.804000	0.34136	0.655000	0.94253	AAG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	160.551212	KEEP		-	165.406044	0.784615	51	14	---	---	---	---	1	1	38	8	0	72	61	15	0	72	2	1	1	164	39	0	240	61	15	0	72	2	TP
PHF12	57649	broad.mit.edu	37	17	27240145	27240145	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr17:27240145T>C	ENST00000577226.1	-	9	1790	c.1444A>G	c.(1444-1446)Aca>Gca	p.T482A	PHF12_ENST00000582655.1_5'UTR|PHF12_ENST00000332830.4_Missense_Mutation_p.T482A|PHF12_ENST00000268756.3_Missense_Mutation_p.T482A			Q96QT6	PHF12_HUMAN	PHD finger protein 12	482	Interaction with SIN3A.	NA			negative regulation of transcription, DNA-dependent|transcription, DNA-dependent	transcriptional repressor complex	protein binding|zinc ion binding		NA	breast(1)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(6)|lung(8)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(2)|urinary_tract(2)	30	all_cancers(5;1.95e-14)|all_epithelial(6;5e-18)|Lung NSC(42;0.01)		Epithelial(11;1.64e-05)|all cancers(11;7.47e-05)|BRCA - Breast invasive adenocarcinoma(11;9.79e-05)			TTGTCAGCTGTTTGCAGGGAG	0.542	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						180	152	161	NA		NA	NA	17		NA											NA				27240145		2203	4300	6503	SO:0001583	missense			ENSG00000109118	HGNC:20816	NM_020889	Approved	uc002hdg.1	NA	Q0VAI5|Q6ZML2|Q9BV34|Q9H7U9|Q9P205	ENST00000577226.1	37		.	.	.	.	.	.	.	.	.	.	T	8.525	0.869758	0.17322	.	.	ENSG00000109118	ENST00000332830;ENST00000378879;ENST00000268756	D;D;D	0.94000	-3.33;-3.29;-3.29	5.55	3.36	0.38483	.	0.399934	0.28072	N	0.016703	T	0.78266	0.4256	N	0.01874	-0.695	0.33773	D	0.623249	B;B;B;B;B	0.06786	0.0;0.0;0.001;0.0;0.0	B;B;B;B;B	0.04013	0.0;0.0;0.001;0.0;0.0	T	0.75274	-0.3375	10	0.13470	T	0.59	-14.6431	7.8404	0.29395	0.0:0.1751:0.0:0.8249	.	464;482;482;482;482	B4DFE2;Q96QT6-2;Q2TAK2;C9J9G2;Q96QT6	.;.;.;.;PHF12_HUMAN	A	482	ENSP00000329933:T482A;ENSP00000368157:T482A;ENSP00000268756:T482A	ENSP00000268756:T482A	T	-	1	0	PHF12	24264271	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	2.099000	0.41767	2.113000	0.64589	0.460000	0.39030	ACA	PHF12-004	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000446737.3	356.792215	KEEP		-	361.851855	0.357895	102	183	---	---	---	---	1	0.9988565	7	15	0	240	109	199	0	240	2	0	0	0	0	0	0	109	199	0	240	2	TP
SAMHD1	25939	broad.mit.edu	37	20	35547889	35547889	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chr20:35547889G>A	ENST00000262878.4	-	7	929	c.730C>T	c.(730-732)Ctt>Ttt	p.L244F	SAMHD1_ENST00000373694.5_Missense_Mutation_p.L29F	NM_015474.3	NP_056289.2	Q9Y3Z3	SAMH1_HUMAN	SAM domain and HD domain 1	244	HD.	NA			defense response to virus|innate immune response|regulation of innate immune response	nucleus	metal ion binding|phosphoric diester hydrolase activity		NA	breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(6)|lung(8)|urinary_tract(1)	20		Myeloproliferative disorder(115;0.00878)				GAATTAATAAGGTGCTCAAAC	0.368	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						90	85	87	NA		NA	NA	20		NA											NA				35547889		2203	4299	6502	SO:0001583	missense			ENSG00000101347	HGNC:15925	NM_015474	Approved	uc002xgh.2	NA	B4E2A5|E1P5V2|Q5JXG8|Q8N491|Q9H004|Q9H005|Q9H3U9	ENST00000262878.4	37	CCDS13288.1	.	.	.	.	.	.	.	.	.	.	G	19.91	3.914400	0.72983	.	.	ENSG00000101347	ENST00000262878;ENST00000373694	D;D	0.96830	-2.96;-4.14	5.82	3.66	0.41972	Metal-dependent phosphohydrolase, HD domain (1);Metal-dependent phosphohydrolase, HD subdomain (1);HD domain (1);	0.000000	0.85682	D	0.000000	D	0.97321	0.9124	M	0.80183	2.485	0.58432	D	0.999999	D	0.63880	0.993	D	0.70716	0.97	D	0.96141	0.9100	10	0.72032	D	0.01	-13.2663	6.2995	0.21105	0.1805:0.0:0.6782:0.1412	.	244	Q9Y3Z3	SAMH1_HUMAN	F	244;29	ENSP00000262878:L244F;ENSP00000362798:L29F	ENSP00000262878:L244F	L	-	1	0	SAMHD1	34981303	1.000000	0.71417	0.496000	0.27539	0.983000	0.72400	3.019000	0.49635	0.622000	0.30249	0.557000	0.71058	CTT	SAMHD1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000079062.2	120.316175	KEEP		-	122.63645	0.345455	38	72	---	---	---	---	1	0.9850949	3	12	0	92	45	80	0	92	2	0	0	0	0	0	0	45	80	0	92	2	TP
PRKX	5613	broad.mit.edu	37	X	3573336	3573336	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chrX:3573336G>C	ENST00000262848.5	-	3	807	c.453C>G	c.(451-453)ttC>ttG	p.F151L	PRKX_ENST00000425240.1_5'UTR	NM_005044.4	NP_005035.1	P51817	PRKX_HUMAN	protein kinase, X-linked	151	Protein kinase.	NA					ATP binding|cAMP-dependent protein kinase activity		NA	kidney(1)|large_intestine(2)|lung(6)|pancreas(1)|skin(2)	12		all_lung(23;0.000396)|Lung NSC(23;0.00123)				CTGCAGAGTAGAAGAGCCCCG	0.587	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						100	89	93	NA		NA	NA	X		NA											NA				3573336		2203	4300	6503	SO:0001583	missense			ENSG00000183943	HGNC:9441	NM_005044	Approved	uc010nde.3	NA		ENST00000262848.5	37	CCDS14125.1	.	.	.	.	.	.	.	.	.	.	G	13.32	2.202976	0.38905	.	.	ENSG00000183943	ENST00000262848	T	0.64991	-0.13	3.7	-1.23	0.09465	Serine/threonine-protein kinase-like domain (1);Serine/threonine-protein kinase, catalytic  domain (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);	0.000000	0.85682	D	0.000000	T	0.67107	0.2858	L	0.47716	1.5	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	T	0.64820	-0.6317	10	0.87932	D	0	-23.8565	8.3092	0.32060	0.7833:0.0:0.2167:0.0	.	151	P51817	PRKX_HUMAN	L	151	ENSP00000262848:F151L	ENSP00000262848:F151L	F	-	3	2	PRKX	3583336	1.000000	0.71417	0.019000	0.16419	0.246000	0.25737	1.205000	0.32308	-0.238000	0.09724	0.529000	0.55759	TTC	PRKX-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000055659.1	223.322344	KEEP		-	226.594975	0.357143	65	117	---	---	---	---	1	0.3002117	3	0	0	194	73	129	0	194	2	0	0	0	0	0	0	73	129	0	194	2	TP
UBA1	7317	broad.mit.edu	37	X	47069360	47069360	+	Silent	SNP	G	G	C			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chrX:47069360G>C	ENST00000335972.6	+	18	2220	c.2037G>C	c.(2035-2037)ctG>ctC	p.L679L	UBA1_ENST00000377351.4_Silent_p.L679L|UBA1_ENST00000377269.3_Silent_p.L127L	NM_003334.3	NP_003325.2	P22314	UBA1_HUMAN	ubiquitin-like modifier activating enzyme 1	679		NA			cell death|protein modification process		ATP binding|ligase activity|protein binding|small protein activating enzyme activity		NA	breast(2)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|lung(7)|ovary(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	31						CACTGCGGCTGGCAGGCACTC	0.607	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						74	70	71	NA		NA	NA	X		NA											NA				47069360		2202	4300	6502	SO:0001819	synonymous_variant			ENSG00000130985	HGNC:12469	NM_003334	Approved	uc004dhj.4	NA	Q5JRR8|Q96E13	ENST00000335972.6	37	CCDS14275.1																																																																																			UBA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000056389.1	232.126711	KEEP		+	234.182727	0.390863	77	120	---	---	---	---	1	1	22	160	0	224	108	183	0	224	2	0	0	0	0	0	0	108	183	0	224	2	TP
OGT	8473	broad.mit.edu	37	X	70767687	70767687	+	Intron	SNP	C	C	T			GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-26-5136-Tumor-SM-1QEU6	GBM-TCGA-26-5136-Normal-SM-1QEV2	g.chrX:70767687C>T	ENST00000373719.3	+	5	748				OGT_ENST00000373701.3_Intron	NM_181672.2|NM_181673.2	NP_858058.1|NP_858059.1	O15294	OGT1_HUMAN	O-linked N-acetylglucosamine (GlcNAc) transferase	NA		NA			cellular response to retinoic acid|positive regulation of granulocyte differentiation|positive regulation of histone H3-K4 methylation|positive regulation of proteolysis|protein O-linked glycosylation|signal transduction	cytosol|MLL5-L complex	enzyme activator activity|protein binding|protein N-acetylglucosaminyltransferase activity		NA	breast(6)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(2)|kidney(4)|large_intestine(5)|liver(3)|lung(9)|ovary(3)|pancreas(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	43	Renal(35;0.156)					TTTTTTTTTTCCCTTTACAAA	0.458	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000147162	HGNC:8127	NM_003605, NM_181672	Approved	uc004eaa.2	NA	Q7Z3K0|Q8WWM8|Q96CC1|Q9UG57	ENST00000373719.3	37	CCDS14414.1																																																																																			OGT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000081829.3	-30.922625	KEEP		+	8.473991	0.040698	7	165	---	---	---	---	1	0.400553	7	27	1	144	11	180	1	144	3	0	0	0	0	0	0	11	180	1	144	2	TP
